Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia.

Lucky L Shokane Selente Bezuidenhout Maryke Lundie

Published in: Health SA = SA Gesondheid (2023)

The administration of the correct doses of G-CSF can reduce both the severity and duration of neutropaenia. Over-prescribing and incorrect dosing may contribute to patient morbidity and add to the financial burden of healthcare.

Keyphrases

chemotherapy induced
healthcare
primary care
case report
peripheral blood
risk factors
emergency department
adverse drug
young adults
health insurance